216 related articles for article (PubMed ID: 22128410)
1. Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.
Merlo LG; Ansari S; Singh B; Teferedgin FF; Cervellione KL; Gintautas J; Babury MA
Proc West Pharmacol Soc; 2009; 52():11-3. PubMed ID: 22128410
[TBL] [Abstract][Full Text] [Related]
2. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
3. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
Barthwal MS
Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of parapneumonic effusions and pleural empyemas].
Hamm H
Pneumologie; 2005 Oct; 59(10):696-703. PubMed ID: 16222582
[TBL] [Abstract][Full Text] [Related]
6. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.
Laisaar T; Püttsepp E; Laisaar V
Thorac Cardiovasc Surg; 1996 Oct; 44(5):252-6. PubMed ID: 8948554
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase.
Ekingen G; Güvenç BH; Sözübir S; Tuzlaci A; Senel U
Eur J Cardiothorac Surg; 2004 Sep; 26(3):503-7. PubMed ID: 15302043
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion.
Hamblin SE; Furmanek DL
Pharmacotherapy; 2010 Aug; 30(8):855-62. PubMed ID: 20653362
[TBL] [Abstract][Full Text] [Related]
12. Parapneumonic pleural effusion and empyema.
Koegelenberg CF; Diacon AH; Bolliger CT
Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
[TBL] [Abstract][Full Text] [Related]
13. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
14. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
15. Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: A randomised, prospective study.
Wang JN; Yao CT; Yeh CN; Liu CC; Wu MH; Chuang HY; Wu JM
Int J Clin Pract; 2006 Oct; 60(10):1225-30. PubMed ID: 16981967
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
[TBL] [Abstract][Full Text] [Related]
18. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions.
Henke CA; Leatherman JW
Am Rev Respir Dis; 1992 Mar; 145(3):680-4. PubMed ID: 1546851
[TBL] [Abstract][Full Text] [Related]
19. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural streptokinase in multiloculated malignant pleural effusion.
Dixit R; Dixit K; Bansal R
Indian J Chest Dis Allied Sci; 2004; 46(1):59-62. PubMed ID: 14870872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
